Alpine Global Management, LLC Gilead Sciences, Inc. Transaction History

Alpine Global Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 06, 2024	BUY	$71.58 - $87.29 $247,308 - $301,586	3,455 New	3,455 $253,000
Q4 2023 Aug 06, 2024	BUY	$73.27 - $83.09 $234,024 - $265,389	3,194 New	3,194 $258,000
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $234,024 - $265,389	3,194 New	3,194 $258,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $777,678 - $977,795	-12,523 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $905,913 - $1.05 Million	12,523 New	12,523 $964,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $707,871 - $830,940	-9,949 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $717,422 - $850,341	9,949	9,949 $806,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.